Výsledky vyhledávání - "B. G. Leventhal"

Repetitive low dose oral methotrexate and intravenous mercaptopurine treatment for patients with lower risk B—lineage acute lymphoblastic leukemia. A pediatric oncology group pilot study

Autor: C. P. Steuber, Donald H. Mahoney, Jonathan J. Shuster, D. J. Ganick, C. J. Civin, S J Lauer, Bruce M. Camitta, B. G. Leventhal, B. A. Kamen

Publikováno v: Cancer. 75:2623-2631

Background. This trial evaluated the toxicity and preliminary efficacy of a repeated oral low dose (LD) methotrexate schedule with intravenous mercaptopurine infusions as intensification therapy for children with lower risk B-lineage acute lymphoblas

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::0ec8a587c77a2ecd81d3eae7678443f4
https://doi.org/10.1002/1097-0142(19950515)75:10<2623::aid-cncr2820751033>3.0.co

Zobrazit plný text záznamu

Treatment of recurrent and refractory pediatric solid tumors with high-dose busulfan and cyclophosphamide followed by autologous bone marrow rescue

Autor: L C Strauss, B G Leventhal, Moody D. Wharam, R L Dubowy, Michael L. Graham, C I Civin, A M Yeager, C A Hurwitz, P M Colombani, Joseph Wiley

Publikováno v: Journal of Clinical Oncology. 10:1857-1864

PURPOSE The purpose of this study was to determine the toxicities of and responses to high-dose busulfan and cyclophosphamide with autologous bone marrow transplant (ABMT) in patients with recurrent or refractory pediatric solid tumors. PATIENTS AND

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8918e03549c4a812bbe39812e5c6e8a4
https://doi.org/10.1200/jco.1992.10.12.1857

Zobrazit plný text záznamu

Intermediate-dose methotrexate versus cranial irradiation in childhood acute lymphoblastic leukemia: a ten-year follow-up

Autor: A I, Freeman, J M, Boyett, A S, Glicksman, M L, Brecher, B G, Leventhal, L F, Sinks, J F, Holland

Publikováno v: Medical and pediatric oncology. 28(2)

The cure rate of childhood acute lymphoblastic leukemia (ALL) has improved dramatically. Still there is a paucity of long-term data. With the improving cure rate, the quality of life and avoidance of second cancers have become important concerns. We

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::f961f94946d7e0fd980f2b6a175b5ce5
https://pubmed.ncbi.nlm.nih.gov/8986145

Zobrazit plný text záznamu

Changes in red blood cell methotrexate pharmacology and their impact on outcome when cytarabine is infused with methotrexate in the treatment of acute lymphocytic leukemia in children: a pediatric oncology group study

Autor: M L, Graham, J J, Shuster, B A, Kamen, V J, Land, M J, Borowitz, B, Camitta, D L, Cheo, M P, Harrison, B G, Leventhal, D P, Pinkel, D J, Pullen, P, Steuber, V M, Whitehead

Publikováno v: Clinical cancer research : an official journal of the American Association for Cancer Research. 2(2)

Since it is unclear whether methotrexate and cytarabine are synergistic or antagonistic in the treatment of acute lymphoblastic leukemia, the Pediatric Oncology Group studied the prognostic significance of a potential interaction between these agents

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::fa370ff55e1a2ac32fbf3eac1d01a9fe
https://pubmed.ncbi.nlm.nih.gov/9816176

Zobrazit plný text záznamu

Repetitive low dose oral methotrexate and intravenous mercaptopurine treatment for patients with lower risk B-lineage acute lymphoblastic leukemia. A Pediatric Oncology Group pilot study

Autor: D H, Mahoney, B M, Camitta, B G, Leventhal, J J, Shuster, C J, Civin, D J, Ganick, S J, Lauer, C P, Steuber, B A, Kamen

Publikováno v: Cancer. 75(10)

This trial evaluated the toxicity and preliminary efficacy of a repeated oral low dose (LD) methotrexate schedule with intravenous mercaptopurine infusions as intensification therapy for children with lower risk B-lineage acute lymphoblastic leukemia

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::9ad9ce4023a778b7bb596934d03ed752
https://pubmed.ncbi.nlm.nih.gov/7736409

Zobrazit plný text záznamu

Intensive alternating drug pairs for treatment of high-risk childhood acute lymphoblastic leukemia. A Pediatric Oncology Group pilot study

Autor: S J, Lauer, B M, Camitta, B G, Leventhal, D H, Mahoney, J J, Shuster, S, Adair, J T, Casper, C I, Civin, M, Graham, G, Kiefer

Publikováno v: Cancer. 71(9)

To prevent drug resistance, the authors designed a protocol that featured early intensive rotating drug pairs as part of the therapy for acute lymphoblastic leukemia (ALL).After prednisone, vincristine, asparaginase, and daunorubicin induction, 12 in

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::a287484e2e2c7ee325e16d8cf363987e
https://pubmed.ncbi.nlm.nih.gov/8467463

Zobrazit plný text záznamu

Epstein-Barr virus and childhood Hodgkin's disease in Honduras and the United States

Autor: R F, Ambinder, P J, Browning, I, Lorenzana, B G, Leventhal, H, Cosenza, R B, Mann, E M, MacMahon, R, Medina, V, Cardona, S, Grufferman

Publikováno v: Blood. 81(2)

In industrialized populations, Hodgkin's disease (HD) has an initial peak in young adulthood, whereas in economically developing populations the initial peak occurs in childhood. This pattern resembles that of infection with poliovirus and suggests a

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::e4ce2922304cf3311dc7993920089c32
https://pubmed.ncbi.nlm.nih.gov/8380725

Zobrazit plný text záznamu

Acute neurotoxicity after intrathecal cytosine arabinoside in two adolescents with acute lymphoblastic leukemia of B-cell type

Autor: L M, Resar, P C, Phillips, M B, Kastan, B G, Leventhal, P W, Bowman, C I, Civin

Publikováno v: Cancer. 71(1)

Two adolescents with acute B-cell leukemia (Burkitt leukemia) had acute severe neurotoxicity after treatment with intrathecal (IT) cytosine arabinoside (AraC) at a dose of 50 mg/day for three consecutive days.A 16-year-old boy had a rapidly ascending

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::d754416e96b902aa01c93a070ab72e44
https://pubmed.ncbi.nlm.nih.gov/8416707

Zobrazit plný text záznamu

Antibodies in patients with recurrent respiratory papillomatosis treated with lymphoblastoid interferon

Autor: L M, Thurmond, C M, Brand, B G, Leventhal, N B, Finter, J M, Johnston

Publikováno v: The Journal of laboratory and clinical medicine. 118(3)

Serum specimens from 53 evaluable patients enrolled in a clinical trial of lymphoblastoid interferon in recurrent respiratory papillomatosis were screened for the presence of interferon-binding antibodies by an indirect enzyme immunoassay and evaluat

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::f82583b05c7cf5ad70d8312324206acd
https://pubmed.ncbi.nlm.nih.gov/1919296

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání